Up to EUR70000 per annum: Paramount Recruitment: Full Stack JavaScript Developer in Medical Bioinformatics, Hamburg, Germany A new opportunity for a Full Stack JavaScript Developer, has opened with Hamburg, Germany

Salary range: £41,259 to £49,922pa plus benefitsFixed-term: 3 yearsWe seek an experienced software developer/bioinf...: Wellcome Sanger Institute: Polygenic Risk Score Catalog Developer Grade: Grade 2 Specific Salary range: £41,259 to £49,922pa plus benefits Full Time or Part Time: Hinxton, Cambridgeshire, England

Funding Opportunity RFA-ES-19-004 from the NIH Guide for Grants and Contracts. The purpose of the NIEHS/DOE Nuclear Worker Training Program is to support the development of model programs for the training and education of workers engaged in activities related to hazardous materials and waste generation, removal, containment, transportation and emergency response within the DOE nuclear weapons complex.

Notice NOT-AT-19-033 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-343 from the NIH Guide for Grants and Contracts. The purpose of the MOSAIC Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to support a cohort of early career, independent investigators from diverse backgrounds conducting research in NIH mission areas. The long-term goal of this program is to enhance diversity in the basic biomedical sciences research workforce. The MOSAIC K99/R00 program is designed to facilitate a timely transition of outstanding postdoctoral researchers from diverse backgrounds (e.g., see NIHs Interest in Diversity) from their mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions at research-intensive institutions. The MOSAIC K99/R00 program will provide independent NIH research support during this transition to help awardees launch competitive, independent research careers. Additionally, MOSAIC K99/R00 scholars will be part of organized scientific cohorts that will be expected to participate in mentoring, networking, and professional development activities coordinated by MOSAIC Institutionally-Focused Research Education Award to Promote Diversity (UE5) grantees.

Funding Opportunity PAR-19-342 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (UE5) supports research education activities in the mission areas of the NIH. The over-arching goal of the MOSAIC UE5 program is to support educational activities that encourage individuals from diverse backgrounds, for example those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development and Mentoring Activities. Applications are encouraged from organizations of biomedical researchers (e.g., scientific societies) with a membership of scientists conducting research within the mission of NIH, experience serving as a centralized entity to enhance scientific communication and networking among scientists conducting research, an established record of providing professional development and networking activities for the next generation of biomedical researchers, and a demonstrated commitment to enhancing the diversity of the biomedical research workforce. The program provides support for well-designed courses for skills development and mentoring activities to prepare MOSAIC K99/R00 grantees to transition into, succeed, and advance in independent faculty careers at research-intensive institutions.

Negotiable: Paramount Recruitment: The Director of Bioinformatics will be involved with developing departmental strategy focussing on target identification, biomarkers, target validation and qualification of drug targets, focussing predominantly on cardio-metabolic diseases. Oxford, England

Notice NOT-DA-19-065 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HL-20-030 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) participating Institutes and Centers, in coordination with the U.S. Food and Drug Administration (FDA), seeks highly meritorious clinical trial applications proposing to explore and enable the development of safe and effective regenerative medicine (RM) interventions using adult stem cells. This Funding Opportunity Announcement (FOA), issued as part of the Regenerative Medicine Innovation Project (RMIP), represents one step in fulfilling a statutory provision set forth in the 21st Century Cures Act. Applications submitted in response to this bi-phasic, milestone-driven cooperative agreement FOA are expected to propose highly innovative projects with a focus on solutions to widely-recognized issues in the development of safe and effective RM therapies. Of particular interest are projects using RM products that have undergone appropriate product development and pre-clinical studies and have demonstrated readiness to advance into clinical trials. This FOA seeks Phase I and beyond clinical trial applications that present a strong scientific rationale for the proposed clinical trial and a comprehensive scientific and operational plan. Trials must be relevant to the research mission of one or more participating NIH Institutes and Centers and meet the NIH definition of a clinical trial (see NOT-OD-15-015). Applications are expected to include plans for project management, participant recruitment and retention, performance milestones, conduct of the trial, and dissemination of results. Before the time of award and if applicable, successful applicants must obtain an Investigational New Drug (IND) authorization or Investigational New Device Exemption (IDE) approval to administer the product to humans. Successful applicants proposing the use of adult stem cells as a clinical intervention will be asked to make available representative samples of the source stem cell and clinical-grade stem cell-derived product for in-depth and independ

Funding Opportunity PAR-19-344 from the NIH Guide for Grants and Contracts. EXplainable Artificial Intelligence (XAI) aims to provide strong predictive value along with mechanistic understanding by combining machine learning techniques with effective explanatory techniques. This Funding Opportunity Announcement (FOA) solicits applications in the area of XAI applied to neuroscientific questions of encoding, decoding, and modulation of neural circuits linked to behavior. This FOA encourages collaborations between computationally and experimentally-focused investigators. This FOA seeks machine learning algorithms able to mechanistically explain how experimental manipulations can improve cognitive, affective, or social processing in humans or animals. Proof-of-concept applications aimed at improving the current state of the technology that use XAI to provide unbiased, hierarchical explanations of causal relationships between complex neural and behavioral data are also responsive.

Funding Opportunity RFA-AG-20-031 from the NIH Guide for Grants and Contracts. The goal of this FOA is to support short courses geared to behavioral and social scientists who have existing expertise in aging research and can make research contributions in Alzheimers disease and Alzheimer's disease-related dementias (AD/ADRD) with additional knowledge about the diseaseand related research resources. Fields of behavioral and social science research relevant for this FOA are health economics, labor economics, health services research, healthcare policy, public policy, demography, sociology, social epidemiology, psychology, and social neuroscience. Priority areas of focus include, but are not limited to, the following: dementia care; dementia caregiver research; cognitive and dementia epidemiology; behavioral and social pathways of AD/ADRD; role of social, contextual, environmental, and institutional factors in AD/ADRD; early psychological changes preceding AD/ADRD onset; prevention of AD/ADRD; disparities in AD/ADRD or dementia-related outcomes; and research resources and methods for studying the determinants and impact of AD/ADRD.

Familiarity with bioinformatic analysis or RNA-seq data, and CRISPR targeting and sequencing analysis is strongly encouraged. Degree and Area of Specialization:
From University of Wisconsin–Madison - Wed, 14 Aug 2019 00:57:33 GMT - View all Madison, WI jobs

Notice NOT-AT-19-032 from the NIH Guide for Grants and Contracts

Notice NOT-OD-19-134 from the NIH Guide for Grants and Contracts

Notice NOT-HL-19-717 from the NIH Guide for Grants and Contracts

Notice NOT-HL-19-716 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: Communications Officer Location: Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: Senior Bioinformatician Location: Cambridge, Cambridgeshire, England

Work will use an array of molecular, biochemical, bioinformatic, and genetic techniques. The University of Wisconsin-Madison fulfills its public mission by…
From University of Wisconsin–Madison - Tue, 13 Aug 2019 06:57:28 GMT - View all Madison, WI jobs

Funding Opportunity PAR-19-339 from the NIH Guide for Grants and Contracts. This FOA encourages the integration of cognitive neuroscience approaches to improve traditional assessment of acute and chronic cognitive changes following cancer treatment for non-central nervous system malignancies.